Home Biosimilar Antibodies Protein Tyrosine Kinase PDGFR antibody Tovetumab (Anti-PDGFRA / CD140a) For research use only.
Not for use in humans.

Tovetumab (Anti-PDGFRA / CD140a)

Synonyms: MEDI-575

Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

Tovetumab (Anti-PDGFRA / CD140a)

Purity & Quality Control

≥99

Choose Selective PDGFR Inhibitors

Biological Activity

Description Tovetumab (Anti-PDGFRA / CD140a) is a fully humanized IgG2κ monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. It has a potential to be used in research of glioblastoma and non-small cell lung cancer (NSCLC). MW :145 kD.

Product Details

CAS No. 1243266-04-7
Molecular Weight 145
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tovetumab (Anti-PDGFRA / CD140a) | Tovetumab (Anti-PDGFRA / CD140a) supplier | purchase Tovetumab (Anti-PDGFRA / CD140a) | Tovetumab (Anti-PDGFRA / CD140a) cost | Tovetumab (Anti-PDGFRA / CD140a) manufacturer | order Tovetumab (Anti-PDGFRA / CD140a) | Tovetumab (Anti-PDGFRA / CD140a) distributor